Business

Announcement on Voluntary Disclosure of Obtaining Notice of Approval of Drug Clinical Trial for Holding Subsidiary's Product SCTB39-1

Announcement on Voluntary Disclosure of Obtaining Notice of Approval of Drug Clinical Trial for Holding Subsidiary's Product SCTB39-1

articleSinocelltech Group Limited Class AJune 17, 20254/news/announcement-on-voluntary-disclosure-of-obtaining-notice-of-approval-of-drug-clinical-trial-for-holding-subsidiarys-product-sctb39-1
Announcement on Voluntary Disclosure of Obtaining Notice of Approval of Drug Clinical Trial for Holding Subsidiary's Product SCTB39-1

About this update from Sinocelltech Group Limited Class A

Announcement on Voluntary Disclosure of Obtaining Notice of Approval of Drug Clinical Trial for Holding Subsidiary's Product SCTB39-1The abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Sinocelltech Group Limited Class A